CLINICAL_TRIALS
trial_result
· 2025-12-08
Clinical Trial Update: Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia [Phase 3]
Summary
A Phase 3 clinical trial evaluating DNN.65.21.005 for benign prostatic hyperplasia is planned, with the study currently not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Prostatic Hyperplasia, Benign | Phase 3 | Status: NOT_YET_RECRUITING